Skip to Main Content

1,111

Views

0

CrossRef citations to date

0

Altmetric

Original Articles

Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia

Scott F. Huntingtona Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USAView further author information

,

Enrico de Nigrisb Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Justin Puckettc COVIA Health Solutions, Lansdale, PA, USAView further author information

,

Sachin Kamal-Bahlc COVIA Health Solutions, Lansdale, PA, USACorrespondence[email protected]
View further author information

,

Mohammed Farooquib Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Katherine Rylandb Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Eric Sarpongb Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Siyang Lengb Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Xiaoqin Yangb Merck & Co., Inc., Rahway, NJ, USAView further author information

&

Jalpa A. Doshid Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAView further author information